FMP
Mauna Kea Technologies SA
MKEA.PA
EURONEXT
Inactive Equity
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
0.622 EUR
0.002 (0.322%)
About
ceo
Mr. Alexandre Loiseau Ph.D.
sector
Healthcare
industry
Medical - Devices
website
https://www.maunakeatech.com
exchange
EURONEXT
Description
Mauna Kea Technologies SA develops and markets medical devices in Europe, the Middle East, Africa, the United States, Latin America, and Asia. The company designs, develops, and markets tools to visualize and detect cell abnormalities in real time during standard gastrointestinal and pulmonary endoscopy procedures. Its flagship product is Cellvizio, a confocal miniprobe endomicroscopy system which provides physicians and researchers high-resolution images of tissues at the cellular level. The company was incorporated in 2000 and is headquartered in Paris, France.
CIK
N/A
ISIN
FR0010609263
CUSIP
F6099Z105
Address
9, rue d'Enghien
Phone
33 1 48 24 03 45
Country
FR
Employee
68
IPO Date
Jul 6, 2011
Key Executives
